GRUPO DE EPIDEMIOLOGÍA AMBIENTAL Y MOLECULAR
GEPIMOL
Complexo Hospitalario Universitario da Coruña
La Coruña, EspañaPublicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (7)
2018
-
Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies
Expert Opinion on Drug Safety, Vol. 17, Núm. 6, pp. 573-579
2014
-
Cabazitaxel for metastatic castration-resistant prostate cancer: Safety data from the Spanish expanded access program
Expert Opinion on Drug Safety, Vol. 13, Núm. 9, pp. 1165-1173
2013
-
Dolor como factor predictor de depresión en el paciente oncológico: estudio de casos y controles. Estudio D-PRESS
Revista de la Sociedad Espanola del Dolor, Vol. 20, Núm. 3, pp. 113-121
-
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
British Journal of Cancer, Vol. 108, Núm. 12, pp. 2565-2572
2011
-
Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients
Expert Opinion on Pharmacotherapy, Vol. 12, Núm. 16, pp. 2433-2439
2009
2003
-
Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer
Lung Cancer, Vol. 39, Núm. 1, pp. 77-84